PTH and hepatocellular carcinoma: To evaluate an MRI-based strategy for quantifying intra- and peritumoralheterogeneity (ITH and PTH) in hepatocellular carcinoma (HCC) anddevelop ITH- and PTH-based models for diagnosing microvascular invasion(MVI) and stratifying prognostic risk.